health
Semaglutide improved cardiac imaging measures in obesity-related HFpEF
A pre-specified CAMEO-SEMA imaging substudy found that semaglutide improved left atrial strain and left ventricular filling measures over 52 weeks in people with obesity-related heart failure with preserved ejection fraction. The imaging changes were associated with lower pressure during exercise.